NCT07012148View on ClinicalTrials.gov

Optimizing Therapy in Epilepsy Using Seizure Forecasts Via EEG and Wearables

NARecruitingINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

October 31, 2025

Primary Completion Date

December 31, 2028

Study Completion Date

December 31, 2029

Conditions
Focal EpilepsyGeneralized SeizureDrug Refractory Epilepsy
Interventions
DEVICE

UNEEG SubQ device

Subjects will be implanted with the UNEEG SubQ device in the neurosurgical operating suite under general anesthesia. Electrodes will be placed over the temporal lobe of the hemisphere established as the origin of seizures by previous EEG monitoring. Only one UNEEG device will be placed, and only the seizure onset hemisphere will be covered.

Trial Locations (1)

55905

RECRUITING

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
collaborator

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

lead

Mayo Clinic

OTHER

NCT07012148 - Optimizing Therapy in Epilepsy Using Seizure Forecasts Via EEG and Wearables | Biotech Hunter | Biotech Hunter